Research
Hormonal
Bariatric surgery achieves 25%–35% total body weight loss with durability extending beyond 10 years.
Bariatric surgery should be considered for long-term weight management in obese patients.
StrongSupportsmedium confidence
Procedures such as sleeve gastrectomy and Roux-en-Y gastric bypass consistently achieve 25%–35% total body weight loss, with durability extending beyond 10 years.
Why this rating
Based on findings from multiple studies referenced in the abstract.
Source
Anti Obesity Drugs and Bariatric Surgery: Complementary Noncompeting Strategies in Obesity Management
Pawanindra Lal · Journal of Bariatric Surgery · 2025
DOI 10.4103/jbs.jbs_1_26
review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →